Introduction
Children:
- The current evidence base is insufficient to make a recommendation regarding pharmacotherapy for children with depression.
Adolescents:
- For the treatment of depression in adolescents, the selective serotonin reuptake inhibitor (SSRI) fluoxetine (Prozac) is recommended as a first-line medication over other medications, due in part to safety concerns with other medications.
Please see Tables 1 and 2 in the full guideline document (PDF, 115MB)opens in new window as well as the evidence grid located in the supplement for more information.
Selective Serotonin Reuptake Inhibitors
The neurotransmitter serotonin is involved in the functioning of brain regions that underpin how we feel and behave. SSRIs help regulate the amount of serotonin that is active in the synapses between neurons.
For adolescents with depression, the following is the typical dosage range for the recommended first-line medication:
- fluoxetine (Prozac): 20-40 mg daily
Side effects and frequency of prescriber visits
While research has shown that adolescents may benefit from receiving fluoxetine for the prevention of relapse of depression, adolescents may report different responses to medication. Side effects of SSRIs range from mild effects that can be tolerated or managed through over-the-counter remedies (e.g., headaches, nausea, drowsiness) to severe side effects that may require altering the dose or discontinuing the medication (e.g., suicidal ideation).
Upon initially being prescribed medication, the adolescent will likely see the prescriber at least a few times within the first eight weeks to check whether they are taking the medication as prescribed, as well as to determine whether the dose is optimal and whether the adolescent is experiencing any adverse side effects. Once the adolescent has a stable medication dosage and reports a decrease of symptoms, visits to the prescriber will likely be less frequent.
References and resources
American Psychological Association. (2010). Talking with your child’s pediatrician about behavioral problems and medication. https://www.apa.org/helpcenter/children-medication
American Psychological Association, Div. 53: Society of Clinical Child & Adolescent Psychology. (2018, Oct. 12). Therapy or medication? https://effectivechildtherapy.org/therapies/therapy-or-medication/opens in new window
Cipriani, A., Zhou, X., Del Giovane, C., Hetrick, S.E., Qin, B., Whittington, C, Coghill, D., Zhang, Y., Hazell, P., Leucht, S., Cuijpers, P., Pu., J., Cohen, D., Ravindran, A. V., Liu, Y., Michael, K. D., Yang, L., Liu, L. & Xie, P. (2016). Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: A network meta-analysis. The Lancet, 388(10047), 881-890. https://doi.org/10.1016/S0140-6736(16)30385-3opens in new window
Emslie, G.J., Heilgenstein, J.H., Hoog, S.L., Wagner, J.D., Findling, R.L., McCracken, J.T, Nilsson, M.E. & Jacobson, J.G. (2004). Fluoxetine treatment for prevention of relapse for depression in children and adolescents: A double-blind, placebo-controlled study. Journal of the American Academy of Child & Adolescent Psychiatry, 43(11), 1397-1405. https://doi.org/10.1097/01.chi.0000140453.89323.57opens in new window
Kaiser Permanente. (2018). Adult & adolescent depression screening, diagnosis, and treatment guideline. https://wa.kaiserpermanente.org/static/pdf/public/guidelines/depression.pdf (PDF, 253KB)opens in new window
Before taking any medications, over-the-counter drugs, supplements or herbs, consult a health care provider for a thorough evaluation. American Psychological Association does not endorse any medications, vitamins or herbs. A qualified health care provider should make a decision based on each person's medical history and current prescriptions. The medication summaries provided do not include all of the information important for patient use and should not be used as a substitute for professional health care advice. The prescribing professional should be consulted concerning any questions that you have.